Your browser doesn't support javascript.
loading
Predictors of mood or anxiety problems among transgender individuals seeking hormone therapy.
Strenth, Chance R; Pagels, Patti; SoRelle, Jeffrey A; Gonzalez, Leo; Day, Philip G; Gimpel, Nora E; Levy Kamugisha, Emily I; Moore, Rachel M; Arnold, Elizabeth Mayfield.
Afiliação
  • Strenth CR; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
  • Pagels P; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
  • SoRelle JA; Department of Pathology, UT Southwestern Medical Center, Dallas, TX, United States.
  • Gonzalez L; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
  • Day PG; Family Medicine and Community Health, University of Massachusetts Chan Medical School, Worcester, MA, United States.
  • Gimpel NE; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
  • Levy Kamugisha EI; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
  • Moore RM; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
  • Arnold EM; Department of Family and Community Medicine, UT Southwestern Medical Center, Dallas, TX, United States.
Fam Pract ; 40(2): 273-281, 2023 03 28.
Article em En | MEDLINE | ID: mdl-36250448
ABSTRACT

BACKGROUND:

Mental health needs of transgender individuals can be complex with individual, social, and medical factors impacting symptoms. This study examines predictors of mood or anxiety problems among transgender individuals seeking hormone therapy (HT).

METHODS:

A retrospective chart review was conducted at 2 clinics providing gender-affirming HT. Cross-sectional data from initial patient encounters (N = 311) were used in this study. Bivariate correlations and multiple logistic regression analyses were carried out.

RESULTS:

Transgender women (TW) were 2.2 times more likely to have mood or anxiety problems while transgender men (TM) were 2.6 times more likely as the number of medical comorbidities increased. For both TW and TM, White race significantly increased the likelihood of mood or anxiety problems. Neither previous nor current HT were associated with mood or anxiety problems for TW and TM. However, receiving multiple gender-affirming procedures decreased the likelihood of mood or anxiety problems for TM.

CONCLUSIONS:

Gender-affirming care and addressing comorbidities can be important aspects of mental health needs for transgender individuals.
The majority of transgender men and women reported 1 or more chronic health conditions. These health conditions were associated with transgender individuals being more likely to have a mood or anxiety problem. Currently receiving or previously receiving hormonal therapy was not associated with mood or anxiety problems for transgender men or women, but having received 1 or multiple gender-affirming procedures was associated with a decrease in likelihood of having a mood or anxiety problem for transgender men. White race also was associated with increased likelihood of having a mood or anxiety problem for transgender men and women. These results highlight the need for primary care physicians to take a comprehensive approach when dealing with the mental health needs of transgender patients by ensuring that general health care needs are met while receiving gender-affirming care.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas Transgênero Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pessoas Transgênero Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article